2. INGREDIENTS/IDENTITY INFORMATION
|
Ingredient Sequence Number:
|
01
|
Ingredient:
|
Lidocaine
|
CAS Number:
|
137-58-6
|
RTECS Number:
|
AN7525000
|
Ingredient Sequence Number:
|
02
|
Ingredient:
|
Benzyl Alcohol
|
CAS Number:
|
100-51-6
|
RTECS Number:
|
DN315000
|
Ingredient Sequence Number:
|
03
|
Ingredient:
|
Carbomer 940
|
CAS Number:
|
9003-01-4
|
RTECS Number:
|
AT4680000
|
Ingredient Sequence Number:
|
04
|
Ingredient:
|
Cholesterol
|
CAS Number:
|
57-88-5
|
RTECS Number:
|
FZ8400000
|
Ingredient Sequence Number:
|
05
|
Ingredient:
|
Hydrogenated Soy Lecithin
|
CAS Number:
|
97281-48-6
|
RTECS Number:
|
|
Ingredient Sequence Number:
|
06
|
Ingredient:
|
Isopropyl Myristate
|
CAS Number:
|
9005-63-6
|
RTECS Number:
|
WG2932500
|
Ingredient Sequence Number:
|
07
|
Ingredient:
|
Polysorbate 80
|
CAS Number:
|
9005-63-6
|
RTECS Number:
|
WG2932500
|
Ingredient Sequence Number:
|
08
|
Ingredient:
|
Propylene Glycol
|
CAS Number:
|
57-55-6
|
RTECS Number:
|
TY2000000
|
Ingredient Sequence Number:
|
09
|
Ingredient:
|
Vitamin E Acetate
|
CAS Number:
|
7695-91-2, 58-95-7
|
Ingredient Sequence Number:
|
10
|
Ingredient:
|
Water
|
CAS Number:
|
7732-18-5
|
RTECS Number:
|
ZC0110000
|
3. HAZARD IDENTIFICATION
|
Emergency Overview
|
Appearance:
|
White to off-white, yellowish cream
|
Caution!
|
Possible eye, skin and respiratory tract irritation. May cause topical analgesia. Ingestion
is toxic.
|
Hazardous Materials Identification (HMIS):
|
Health - 1 Flammability - 1 Reactivity - 0
|
National Fire Protection Association (NFPA):
|
Health - 1 Flammability - 1 Reactivity - 0
|
Potential Health Effects
|
Routes of Exposure:
|
Inhalation:
|
Unlikely route of exposure. May cause tingling/numbness in exposed areas
(parasthesia). May produce a reduced heart rate and reduction in blood pressure with a
resulting feeling of dizziness. May cause irritation to the respiratory tract. Symptoms may
include coughing, sore throat, labored breathing, and chest pain.
|
Skin:
|
May cause numbness. May be absorbed through skin with possible side effects.
May cause irritation or sensitization in sensitive individuals. Prolonged and/or repeated
contact may cause defatting of the skin and dermatitis
|
Ingestion:
|
May produce numbness of the tongue and anesthetic effects on the stomach. May
cause irritation of the digestive tract. Symptoms may include nausea, vomiting and
diarrhea.
|
Eye:
|
May cause numbness. May cause eye irritation. May cause excessive watering of
the eye (lacrimation).
|
Chronic Exposure:
|
Repeated exposure of animals to high levels of lidocaine produces adverse
effects on the: liver, central nervous system. Prolonged or repeated exposure may cause
dermatitis.
|
4. FIRST AID MEASURES
|
Take precautions to ensure your own health and safety before attempting rescue and providing first aid.
|
Inhalation:
|
Unlikely route of exposure. Remove from exposure to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid if
cough or other symptoms appear.
|
Eye:
|
Flush with copious amounts of eyewash solution or clean water for at least 15 minutes.
Assure adequate flushing by occasionally lifting the upper and lower eyelids with fingers.
Obtain medical attention.
|
Skin:
|
Flush with copious amounts of soap and water for at least 15 minutes. Remove
contaminated shoes and clothing. Get medical aid if irritation develops or persists. Wash
clothing before reuse. Thoroughly clean shoes before reuse.
|
Ingestion:
|
If victim is conscious and alert, give 2-4 cupfuls or milk or water. Never give anything by mouth to an unconscious person. Get medical aid.
|
Note to Physician:
|
Treat symptomatically and supportively.
|
5. FIRE FIGHTING
|
Flash Point:
|
Not determined
|
Autoignition Temperature:
|
Not determined
|
Flammable or Explosive Limits (Approximate percent by volume in air)
Lower Explosive Limit:
|
Not determined
|
Upper Explosive Limit:
|
Not determined
|
Extinguishing Media:
|
Foam, water spray (fog), dry chemical carbon dioxide and
vaporizing liquid type fire extinguishing agents may all be suitable for extinguishing fires
involving this type of product, depending on size or potential size of fire and circumstances
related to the situation. Plan fire protection and response strategy through consultation with
local fire protection authorities or appropriate specialists.
|
Fire Fighting Procedures:
|
Wear a self-contained breathing apparatus (SCBA) equipped with a
full facepiece and operated in a pressure-demand mode (or other positive pressure mode) and
approved protective clothing. Personnel without suitable respiratory protection must leave the
area to prevent significant exposure to hazardous gases from combustion, burning, or
decomposition. In an enclosed or poorly ventilated area, wear SCBA during cleanup
immediately after a fire as well as during the attack phase of firefighting operations. During a
fire, irritating and highly toxic gases may be generated by thermal decomposition or
combustion.
|
Hazardous Decomposition Products:
|
Carbon irritating and highly toxic fumes and gases, carbon dioxide.
|
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
|
Exposure limit for total product:
|
Not available
|
Ventilation:
|
A system of local and/or general exhaust is recommended to keep employee
exposures as low as possible. Local exhaust ventilation is generally preferred because it can
control the emissions of the contaminant at its source, preventing dispersions of it into the
general work area.
|
Respiratory Protection:
|
Not expected to require personal respirator usage.
|
Skin Protection:
|
Wear appropriate protective gloves to prevent skin exposure. Wear
appropriate protective clothing to prevent skin exposure.
|
Eye Protection:
|
Wear appropriate protective eyeglasses or chemical safety goggles as
described by OSHA’s eye and face protection regulations in 29 CFR 1910.134. Maintain eye
wash fountain and quick-drench facilities in work area.
|
Personal Hygiene:
|
Clean PPE and work clothing contaminated with product prior to use.
|
11. TOXICOLOGICAL INFORMATION
|
Nature of Hazard and Toxicity Information
|
Lidocaine:
|
Oral median lethal dose 317 mg/kg (rat)
|
Benzyl Alcohol:
|
Draize test, rabbit skin: 100 mg/24H Moderate; oral, mouse: LD50 = 1360
mg/kg; Oral, rabbit: LD50 = 1040 mg/kg Oral, rat: LD50 =1230 gm/kg; Skin, rabbit: LD50
2 gm/kg. Not listed as a carcinogen by ACGIH, IARC, NIOSH, NTP, or OSHA.
Mutagenicity: DNA repair (Bacteria= Bacillus subtilis) = 21 mg/disc Mutation in
microorganisms (Mouse lymphocyte) = 250 mg/L Other studies: Standard Draize test (skin,
Human) = 16 mg/48H; Mild Standard Draize test (skin, rabbit) = 100 mg/24H; Moderate.
|
Carbomer 940:
|
IARC: Group 3 carcinogen Oral mouse: LD50 = 4600 mg/kg;
Oral, rat: LD50 = 2500 mg/kg
|
Cholesterol:
|
No LD50/LC information found relating to normal routes of occupational
exposure. Investigated as tumorigen, mutagen, reproductive effector. NTP Carcinogen –
Known: No Anticipated: No IARC Category: 3
|
Hydrogenated Soy Lecithin:
|
This product can be considered as nontoxic for human
beings and animals.
|
Isopropyl Myristate:
|
Draize test, rabbit, skin: 426 mg/24H Mild Draise test, rabbi,t skin:
100 mg/24 H Severe Oral, mouse LD50 = 49700 mg/kg Skin, rabbit: LD50 = 5 g/kg
Carcinogenicity: Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
|
Polysorbate 80:
|
Irritation Data (std Draize, rabbit): Eye = 150 mg, mild Toxicity
Data: IPR-RAT LD50: 6804 mg/kg IVN-RAT LD50: 1790 mg/kg ORL-RAT LD50:
34500 ul/kg ORL-MUS LD 50: 25 g/kg IPR-MUS LD50: 7600 mg/kg IVN-MUS LD50: 4500 mg/kg Investigated as a tumorigen, mutagen, reproductive effector.
|
Propylene Glycol:
|
Oral LD50 Rat >5 g/kg Dermal LD50 Rabbit >2 g/kg. Skin
irritation: This material is expected to be slightly irritating. Eye irritation: This material is
expected to be slightly irritating. Reproductive and Developmental Toxicity: No
reproductive or developmental risk to humans is expected from exposure to this product.
Developmental Toxicity: This chemical has been tested in laboratory animals and no
evidence of teratogenicity, embryotoxicity or fetotoxicity was seen. Mutagenicity: This
material has been shown not to be mutagenic.
|
Vitamin E Acetate:
|
Acute oral, single dose, rat: >16,000 mg/kg Acute, dermal, single
dose, rat: >3000 mg/kg Irritation eye, single dose, rabbit: non-irritating Irritation skin,
single dose, rabbit: practically non-irritating
|
12. ECOLOGICAL INFORMATION
|
Nature of Hazard and Ecological Information
|
Lidocaine:
|
Low toxicity to aquatic organisms. LC0 (zebra fish)(96 hour) 106 mg/L).
EC50 (Daphnia magna) (48 hour) 112 mg/L EC 50 (green algae (72 hour) 780 mg/L EC50
(Microtox test) (15 minutes) > 1000 mg/L
|
Benzyl Alcohol:
|
Flathead Minnow: LC50 = 46.41 mg/L; 96 hr.; Static, Soft
Flathead Minnow: LC50 = 59.30 mg/L, 96 hr.; Static, Hard Bluegill/Sunfish: LC50 =
25.05 mg/L 96 hr.; Static, Hard Goldfish: LC50 = 64.74 mg/L, 96 hr.; Static, Hard
WasteWater flea Daphnia: EC50 = 400.0 mg/L 48 hr.; Unspecified/Water flea Daphnia:
EC50 = 23.0 mg/L; 48 hr.; Unspecified/Bacteria Phytobacterium phosphoreum: EC50 =
71.4 mg/L 5,15,30 minutes Microtox test, 15 degrees Clog Pow: 1.1 Fish toxicity: LC5-
(48-96 hr) flathead minnow 770-460 mg/L, static bioassay at 18-22°C
|
Carbomer 940:
|
Bluegill/Sunfish: LC50 = 580-2000 mg/L; 96 hr;
Unspecified/Water flea Daphnia: EC50 = 168-280 mg/L; 96 hr; Unspecificed
|
Cholesterol:
|
No information found.
|
Hydrogenated Soy Lecithin:
|
Ecological completely harmless.
|
Isopropyl Myristate:
|
No information found.
|
Polysorbate 80:
|
No information found.
|
Propylene Glycol:
|
Goldfish 224 hr LC50: >5000 mg/L (Measured, Static) Rainbow
Trout (Salmogairdneri) Lethal Dose (24 hr Exposure) >50000 mg/L (Nominal, Static)
Brine Shrimp 24 hr LC50: >10000 mg/L (Nominal, Static) Daphine Magna, 48 hr EC50:
>10000 mg/L (Nominal, Static)
|
Vitamin E Acetate:
|
n-octanol/water partition coefficient: 12.2
|
Clean Air Act:
|
This product does not contain any hazardous air pollutants. This product
does not contain any Class 1 Ozone depletors. This product does not contain any Class 2
Ozone depletors.
|
